A year of experience with COVID-19 in patients with cancer: A nationwide study.
Mina KhosravifarSogol KoolajiNegar RezaeiAli GhanbariSeyedeh Melika HashemiErfan GhasemiAli BitarafOzra Tabatabaei-MalazyNazila RezaeiSahar Mohammadi FatehArezou Dilmaghani-MarandRosa HaghshenasAmeneh KazemiErfan PakatchianFarzad KompaniShirin DjalaliniaPublished in: Cancer reports (Hoboken, N.J.) (2022)
Given the immunocompromised state of patients with malignancy and their vulnerability to Covid-19 complications, collecting data on the comorbidities and their effects on the disease outcome can build on a better clinical view and help clinicians make decisions to manage these cases better; for example, determining special clinical care, especially in the shortage of health services.